The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

Data submitted to the UK drugs regulator show a total of 82 deaths related to glucagon-like peptide-1 receptor agonists, the class of drugs used for weight loss and type 2 diabetes. Data from the ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according ...

The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

PMGC Holdings Inc. (the “Company,” “PMGC,” “us,” or “we”) (Nasdaq:ELAB), a diversified holding company, today announced an ...

While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm ...

PMGC Holdings Inc. (the "Company," "PMGC," "us," or "we") (Nasdaq:ELAB), a diversified holding company, today announced an update on its capital ...

There used to be no specific treatments for heart failure with preserved ejection fraction, but recent clinical trials show ...

A target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with ...

Investing.com -- Wall Street analysts initiated coverage on Metsera with bullish outlook given the biotech firm’s ...